The pathogenic role of IgA1 O-linked glycosylation in the pathogenesis of IgA nephropathy (review article)

Nephrology

Volumn 12, Issue 3, 2007, Pages 275-284

  Barratt, Jonathan ^a,b   Smith, Alice C ^a,b   Feehally, John ^a,b  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

IgA nephropathy; IgA1; O glycosylation; Pathogenesis

Indexed keywords

ANTIGEN; CARBOHYDRATE; CHEMOKINE; COMPLEMENT; CYTOKINE; GLYCAN; GROWTH FACTOR; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN A1; IMMUNOGLOBULIN D; N ACETYLGALACTOSAMINE; PLASMA PROTEIN;

B LYMPHOCYTE; CELL ISOLATION; CELL PROLIFERATION; COMPLEMENT ACTIVATION; CYTOKINE RELEASE; EXTRACELLULAR MATRIX; GENETIC ANALYSIS; GLOMERULOSCLEROSIS; GLYCOSYLATION; HUMAN; IMMUNE COMPLEX DEPOSITION; IMMUNE SYSTEM; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN PRODUCTION; INFLAMMATORY CELL; MESANGIUM CELL; MUCOSA; NEPHRITIS; NONHUMAN; PATHOGENESIS; PHENOTYPE; PHENOTYPIC VARIATION; POLYMERIZATION; PRIORITY JOURNAL; PROTEIN SECRETION; REVIEW; SIALYLATION; SYSTEMIC CIRCULATION; TONSIL CELL;

AMINO ACID SEQUENCE; ANTIGEN-ANTIBODY COMPLEX; COMPLEMENT ACTIVATION; GLOMERULONEPHRITIS, IGA; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN A; MESANGIAL CELLS;

EID: 34248168090     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2007.00797.x     Document Type: Review

References (119)

1. D'Amico G. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. Semin. Nephrol. 2004 24 : 179 96.
2. Barratt J, Feehally J. IgA nephropathy. J. Am. Soc. Nephrol. 2005 16 : 2088 97.
3. Barratt J, Feehally J, Smith AC. Pathogenesis of IgA nephropathy. Semin. Nephrol. 2004 24 : 197 217.
4. Coppo R, Amore A. Aberrant glycosylation in IgA nephropathy (IgAN). Kidney Int. 2004 65 : 1544 7.
5. Kerr MA. The structure and function of human IgA. Biochem. J. 1990 271 : 285 96.
6. Gregory RL. The biological role and clinical implications of IgA. Lab. Med. 1994 25 : 724 8.
7. Ohtsubo K, Marth JD. Glycosylation in cellular mechanisms of health and disease. Cell 2006 126 : 855 67.
8. Arnold JN, Wormald MR, Sim RB, Rudd PM, Dwek RA. The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins. Annu. Rev. Immunol. 2006.
9. Tarelli E, Smith AC, Hendry BM, Challacombe SJ, Pouria S. Human serum IgA1 is substituted with up to six O-glycans as shown by matrix assisted laser desorption ionisation time-of-flight mass spectrometry. Carbohydr. Res. 2004 339 : 2329 35.
10. Iwasaki H, Zhang Y, Tachibana K et al. Initiation of O-glycan synthesis in IgA1 hinge region is determined by a single enzyme, UDP-N-acetyl-alpha-D- galactosamine: Polypeptide N-acetylgalactosaminyltransferase 2. J. Biol. Chem. 2003 278 : 5613 21.
11. Ju T, Brewer K, D'Souza A, Cummings RD, Canfield WM. Cloning and expression of human core 1 beta1,3-galactosyltransferase. J. Biol. Chem. 2002 277 : 178 86.
12. Kudo T, Iwai T, Kubota T et al. Molecular cloning and characterization of a novel UDP-Gal:GalNAc(alpha) peptide beta 1,3-galactosyltransferase (C1Gal-T2), an enzyme synthesizing a core 1 structure of O-glycan. J. Biol. Chem. 2002 277 : 47724 31.
13. Ju T, Cummings RD. A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta 3-galactosyltransferase. Proc. Natl Acad. Sci. USA 2002 99 : 16613 18.
14. Ju T, Cummings RD. Protein glycosylation: Chaperone mutation in Tn syndrome. Nature 2005 437 : 1252.
15. Harduin-Lepers A, Vallejo-Ruiz V, Krzewinski-Recchi MA, Samyn-Petit B, Julien S, Delannoy P. The human sialyltransferase family. Biochimie 2001 83 : 727 37.
16. Hiki Y, Tanaka A, Kokubo T et al. Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix- assisted laser desorption/ionization time-of-flight mass spectrometry. J. Am. Soc. Nephrol. 1998 9 : 577 82.
17. Chintalacharuvu SR, Emancipator SN. The glycosylation of IgA produced by murine B cells is altered by Th2 cytokines. J. Immunol. 1997 159 : 2327 33.
18. Kobayashi I, Nogaki F, Kusano H et al. Interleukin-12 alters the physicochemical characteristics of serum and glomerular IgA and modifies glycosylation in a ddY mouse strain having high IgA levels. Nephrol. Dial. Transplant. 2002 17 : 2108 16.
19. Royle L, Roos A, Harvey DJ et al. Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems. J. Biol. Chem. 2003 278 : 20140 53.
20. Smith AC, Molyneux K, Feehally J, Barratt J. O-glycosylation of serum IgA1 antibodies against mucosal and systemic antigens in IgA nephropathy. J. Am. Soc. Nephrol. 2006 17 : 3520 28.
21. Allen AC, Harper SJ, Feehally J. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy. Clin. Exp. Immunol. 1995 100 : 470 74.
22. Andre PM, Le Pogamp P, Chevet D. Impairment of jacalin binding to serum IgA in IgA nephropathy. J. Clin. Lab. Anal. 1990 4 : 115 19.
23. Coppo R, Amore A, Gianoglio B et al. Serum IgA and macromolecular IgA reacting with mesangial matrix components. Contrib. Nephrol. 1993 104 : 162 71.
24. Hiki Y, Iwase H, Saitoh M et al. Reactivity of glomerular and serum IgA1 to jacalin in IgA nephropathy. Nephron 1996 72 : 429 35.
25. Mestecky J, Tomana M, Crowley-Nowick PA, Moldoveanu Z, Julian BA, Jackson S. Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy. Contrib. Nephrol. 1993 104 : 172 82.
26. Tomana M, Matousovic K, Julian BA, Radl J, Konecny K, Mestecky J. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG. Kidney Int. 1997 52 : 509 16.
27. Horie A, Hiki Y, Odani H et al. IgA1 molecules produced by tonsillar lymphocytes are under-O-glycosylated in IgA nephropathy. Am. J. Kidney Dis. 2003 42 : 486 96.
28. Odani H, Hiki Y, Takahashi M et al. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry. Biochem. Biophys. Res. Commun. 2000 271 : 268 74.
29. Renfrow MB, Cooper HJ, Tomana M et al. Determination of aberrant O-glycosylation in the IgA1 hinge region by electron capture dissociation fourier transform-ion cyclotron resonance mass spectrometry. J. Biol. Chem. 2005 280 : 19136 45.
30. Yasuda Y, Horie A, Odani H, Iwase H, Hiki Y. Application of mass spectrometry to IgA nephropathy: Structural and biological analyses of underglycosylated IgA1 molecules. Contrib. Nephrol. 2004 141 : 170 88.
31. Hiki Y, Odani H, Takahashi M et al. Mass spectrometry proves under-O-glycosylation of glomerular IgA1 in IgA nephropathy. Kidney Int. 2001 59 : 1077 85.
32. Allen AC, Bailey EM, Barratt J, Buck KS, Feehally J. Analysis of IgA1 O-glycans in IgA nephropathy by fluorophore-assisted carbohydrate electrophoresis. J. Am. Soc. Nephrol. 1999 10 : 1763 71.
33. Hiki Y, Iwase H, Kokubo T et al. Association of asialo-galactosyl beta 1-3N-acetylgalactosamine on the hinge with a conformational instability of Jacalin-reactive immunoglobulin A1 in immunoglobulin A nephropathy. J. Am. Soc. Nephrol. 1996 7 : 955 60.
34. Iwase H, Ishii-Karakasa I, Fujii E, Hotta K, Hiki Y, Kobayashi Y. Analysis of glycoform of O-glycan from human myeloma immunoglobulin A1 by gas-phase hydrazinolysis following pyridylamination of oligosaccharides. Anal Biochem. 1992 206 : 202 5.
35. Allen AC. Methodological approaches to the analysis of IgA1 O-glycosylation in IgA nephropathy. J. Nephrol. 1999 12 : 76 84.
36. Moore JS, Kulhavy R, Tomana M et al. Reactivities of N- acetylgalactosamine-specific lectins with human IgA1 proteins. Mol. Immunol. 2007 44 : 2598 2604.
37. Leung JC, Poon PY, Lai KN. Increased sialylation of polymeric immunoglobulin A1: Mechanism of selective glomerular deposition in immunoglobulin A nephropathy? J. Lab. Clin. Med. 1999 133 : 152 60.
38. Amore A, Cirina P, Conti G, Brusa P, Peruzzi L, Coppo R. Glycosylation of circulating iga in patients with iga nephropathy modulates proliferation and apoptosis of mesangial cells. J. Am. Soc. Nephrol. 2001 12 : 1862 71.
39. Hashim OH, Shuib AS, Chua CT. The interaction of selective plant lectins with neuraminidase-treated and untreated IgA1 from the sera of IgA nephropathy patients. Immunol. Invest. 2001 30 : 21 31.
40. Leung JC, Tang SC, Chan DT, Lui SL, Lai KN. Increased sialylation of polymeric lambda-IgA1 in patients with IgA nephropathy. J. Clin. Lab. Anal 2002 16 : 11 19.
41. Xu LX, Zhao MH. Aberrantly glycosylated serum IgA1 are closely associated with pathologic phenotypes of IgA nephropathy. Kidney Int. 2005 68 : 167 72.
42. Iwase H, Katsumata T, Itoh A et al. Detection of enriched Thomsen-Friedenrich antigen on IgA1 from IgA nephropathy patients. J. Nephrol. 2002 15 : 703 8.
43. Allen AC, Bailey EM, Brenchley PE, Buck KS, Barratt J, Feehally J. Mesangial IgA1 in IgA nephropathy exhibits aberrant O-glycosylation: Observations in three patients. Kidney Int. 2001 60 : 969 73.
44. Itoh A, Iwase H, Takatani T et al. Tonsillar IgA1 as a possible source of hypoglycosylated IgA1 in the serum of IgA nephropathy patients. Nephrol. Dial. Transplant. 2003 18 : 1108 14.
45. Matousovic K, Novak J, Yanagihara T et al. IgA-containing immune complexes in the urine of IgA nephropathy patients. Nephrol. Dial. Transplant. 2006 21 : 2478 84.
46. Kokubo T, Hiki Y, Iwase H et al. Evidence for involvement of IgA1 hinge glycopeptide in the IgA1-IgA1 interaction in IgA nephropathy. J. Am. Soc. Nephrol. 1997 8 : 915 19.
47. Hiki Y, Saitoh M, Kobayashi Y. Serum IgA class anti-IgA antibody in IgA nephropathy. Nephron 1991 59 : 552 60.
48. Kokubo T, Hiki Y, Iwase H et al. Protective role of IgA1 glycans against IgA1 self-aggregation and adhesion to extracellular matrix proteins. J. Am. Soc. Nephrol. 1998 9 : 2048 54.
49. Yan Y, Xu LX, Zhang JJ, Zhang Y, Zhao MH. Self-aggregated deglycosylated IgA1 with or without IgG were associated with the development of IgA nephropathy. Clin. Exp. Immunol. 2006 144 : 17 24.
50. Iwase H, Tanaka A, Hiki Y et al. Aggregated human serum immunoglobulin A1 induced by neuraminidase treatment had a lower number of O-linked sugar chains on the hinge portion. J. Chromatogr. B Biomed. Sci. Appl. 1999 724 : 1 7.
51. Takatani T, Iwase H, Itoh A et al. Compositional similarity between immunoglobulins binding to asialo-, agalacto-IgA1-Sepharose and those deposited in glomeruli in IgA nephropathy. J. Nephrol. 2004 17 : 679 86.
52. Tomana M, Novak J, Julian BA, Matousovic K, Konecny K, Mestecky J. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies. J. Clin. Invest. 1999 104 : 73 81.
53. Iwase H, Yokozeki Y, Hiki Y et al. Human serum immunoglobulin G3 subclass bound preferentially to asialo-, agalactoimmunoglobulin A1/Sepharose. Biochem. Biophys. Res. Commun 1999 264 : 424 9.
54. Nakamura I, Iwase H, Arai K et al. Detection of gender difference and epitope specificity of IgG antibody activity against IgA1 hinge portion in IgA nephropathy patients by using synthetic hinge peptide and glycopeptide probes. Nephrology (Carlton) 2004 9 : 26 30.
55. Kokubo T, Hashizume K, Iwase H et al. Humoral immunity against the proline-rich peptide epitope of the IgA1 hinge region in IgA nephropathy. Nephrol. Dial. Transplant. 2000 15 : 28 33.
56. Van Der Boog PJ, van Kooten C, de Fijter JW, Daha MR. Role of macromolecular IgA in IgA nephropathy. Kidney Int. 2005 67 : 813 21.
57. Sano T, Hiki Y, Kokubo T, Iwase H, Shigematsu H, Kobayashi Y. Enzymatically deglycosylated human IgA1 molecules accumulate and induce inflammatory cell reaction in rat glomeruli. Nephrol. Dial. Transplant. 2002 17 : 50 56.
58. Oida E, Nogaki F, Kobayashi I et al. Quantitative trait loci (QTL) analysis reveals a close linkage between the hinge region and trimeric IgA dominancy in a high IgA strain (HIGA) of ddY mice. Eur. J. Immunol. 2004 34 : 2200 208.
59. Hiki Y, Kokubo T, Iwase H et al. Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy. J. Am. Soc. Nephrol. 1999 10 : 760 69.
60. Coppo R, Amore A, Gianoglio B et al. Macromolecular IgA and abnormal IgA reactivity in sera from children with IgA nephropathy. Italian Collaborative Paediatric IgA Nephropathy Study. Clin. Nephrol. 1995 43 : 1 13.
61. Chen A, Chen WP, Sheu LF, Lin CY. Pathogenesis of IgA nephropathy: In vitro activation of human mesangial cells by IgA immune complex leads to cytokine secretion. J. Pathol. 1994 173 : 119 26.
62. Gomez-Guerrero C, Lopez-Armada MJ, Gonzalez E, Egido J. Soluble IgA and IgG aggregates are catabolized by cultured rat mesangial cells and induce production of TNF-alpha and IL-6, and proliferation. J. Immunol. 1994 153 : 5247 55.
63. Lopez-Armada MJ, Gomez-Guerrero C, Egido J. Receptors for immune complexes activate gene expression and synthesis of matrix proteins in cultured rat and human mesangial cells: Role of TGF-beta. J. Immunol. 1996 157 : 2136 42.
64. van den Dobbelsteen ME, Van Der Woude FJ, Schroeijers WE, van den Wall Bake AW, van Es LA, Daha MR. Binding of dimeric and polymeric IgA to rat renal mesangial cells enhances the release of interleukin 6. Kidney Int. 1994 46 : 512 19.
65. Oortwijn BD, Roos A, Royle L et al. Differential glycosylation of polymeric and monomeric IgA: A possible role in glomerular inflammation in IgA nephropathy. J. Am. Soc. Nephrol. 2006 17 : 3529 39.
66. Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells. Clin. Exp. Immunol. 2004 136 : 168 75.
67. Leung JC, Tang SC, Chan LY, Tsang AW, Lan HY, Lai KN. Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy. Nephrol. Dial. Transplant. 2003 18 : 36 45.
68. Novak J, Vu HL, Novak L, Julian BA, Mestecky J, Tomana M. Interactions of human mesangial cells with IgA and IgA-containing immune complexes. Kidney Int. 2002 62 : 465 75.
69. Moura IC, Arcos-Fajardo M, Sadaka C et al. Glycosylation and size of IgA1 are essential for interaction with mesangial transferrin receptor in IgA nephropathy. J. Am. Soc. Nephrol. 2004 15 : 622 34.
70. Zhang JJ, Xu LX, Zhang Y, Zhao MH. Binding capacity of in vitro deglycosylated IgA1 to human mesangial cells. Clin. Immunol. 2006 119 : 103 9.
71. Novak J, Tomana M, Matousovic K et al. IgA1-containing immune complexes in IgA nephropathy differentially affect proliferation of mesangial cells. Kidney Int. 2005 67 : 504 13.
72. Amore A, Conti G, Cirina P et al. Aberrantly glycosylated IgA molecules downregulate the synthesis and secretion of vascular endothelial growth factor in human mesangial cells. Am. J. Kidney Dis. 2000 36 : 1242 52.
73. Peruzzi L, Amore A, Cirina P et al. Integrin expression and IgA nephropathy: In vitro modulation by IgA with altered glycosylation and macromolecular IgA. Kidney Int. 2000 58 : 2331 40.
74. Roos A, Bouwman LH, van Gijlswijk-Janssen DJ, Faber-Krol MC, Stahl GL, Daha MR. Human IgA activates the complement system via the mannan-binding lectin pathway. J. Immunol. 2001 167 : 2861 8.
75. Hiemstra PS, Biewenga J, Gorter A et al. Activation of complement by human serum IgA, secretory IgA and IgA1 fragments. Mol. Immunol. 1988 25 : 527 33.
76. Zhang W, Lachmann PJ. Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes. Immunology 1994 81 : 137 41.
77. Czerkinsky C, Koopman WJ, Jackson S et al. Circulating immune complexes and immunoglobulin A rheumatoid factor in patients with mesangial immunoglobulin A nephropathies. J. Clin. Invest. 1986 77 : 1931 38.
78. Nakamura I, Iwase H, Ohba Y, Hiki Y, Katsumata T, Kobayashi Y. Quantitative analysis of IgA1 binding protein prepared from human serum by hypoglycosylated IgA1/Sepharose affinity chromatography. J. Chromatogr. B Anal Technol. Biomed. Life Sci. 2002 776 : 101 6.
79. Xu LX, Yan Y, Zhang JJ, Zhang Y, Zhao MH. The glycans deficiencies of macromolecular IgA1 is a contributory factor of variable pathological phenotypes of IgA nephropathy. Clin. Exp. Immunol. 2005 142 : 569 75.
80. Linossier MT, Palle S, Berthoux F. Different glycosylation profile of serum IgA1 in IgA nephropathy according to the glomerular basement membrane thickness: Normal versus thin. Am. J. Kidney Dis. 2003 41 : 558 64.
81. Baharaki D, Dueymes M, Perrichot R et al. Aberrant glycosylation of IgA from patients with IgA nephropathy. Glycoconj J. 1996 13 : 505 11.
82. Nishie T, Miyaishi O, Azuma H et al. Development of Immunoglobulin A Nephropathy- Like Disease in {beta}-1,4-Galactosyltransferase-I-Deficient Mice. Am. J. Pathol. 2007 170 : 447 56.
83. Smith AC, de Wolff JF, Molyneux K, Feehally J, Barratt J. O-glycosylation of serum IgD in IgA nephropathy. J. Am. Soc. Nephrol. 2006 17 : 1192 9.
84. Mellis SJ, Baenziger JU. Structures of the O-glycosidically linked oligosaccharides of human IgD. J. Biol. Chem. 1983 258 : 11557 63.
85. Putnam FW, Liu YS, Low TL. Primary structure of a human IgA1 immunoglobulin. IV. Streptococcal IgA1 protease, digestion, Fab and Fc fragments, and the complete amino acid sequence of the alpha 1 heavy chain. J. Biol. Chem. 1979 254 : 2865 74.
86. Takahashi N, Tetaert D, Debuire B, Lin LC, Putnam FW. Complete amino acid sequence of the delta heavy chain of human immunoglobulin D. Proc. Natl Acad. Sci. USA 1982 79 : 2850 54.
87. Preud'homme JL, Petit I, Barra A, Morel F, Lecron JC, Lelievre E. Structural and functional properties of membrane and secreted IgD. Mol. Immunol. 2000 37 : 871 87.
88. Kerr WG, Hendershot LM, Burrows PD. Regulation of IgM and IgD expression in human B-lineage cells. J. Immunol. 1991 146 : 3314 21.
89. Nicholson IC, Brisco MJ, Zola H. Memory B lymphocytes in human tonsil do not express surface IgD. J. Immunol. 1995 154 : 1105 13.
90. Greer MR, Barratt J, Harper SJ, Allen AC, Feehally J. The nucleotide sequence of the IgA1 hinge region in IgA nephropathy. Nephrol. Dial. Transplant. 1998 13 : 1980 83.
91. Barratt J, Bailey EM, Buck KS et al. Exaggerated systemic antibody response to mucosal Helicobacter pylori infection in IgA nephropathy. Am. J. Kidney Dis. 1999 33 : 1049 57.
92. Layward L, Finnemore AM, Allen AC, Harper SJ, Feehally J. Systemic and mucosal IgA responses to systemic antigen challenge in IgA nephropathy. Clin. Immunol. Immunopathol. 1993 69 : 306 13.
93. Leinikki PO, Mustonen J, Pasternack A. Immune response to oral polio vaccine in patients with IgA glomerulonephritis. Clin. Exp. Immunol. 1987 68 : 33 8.
94. Ots M, Uibo O, Metskula K, Uibo R, Salupere V. IgA-antigliadin antibodies in patients with IgA nephropathy: The secondary phenomenon? Am. J. Nephrol. 1999 19 : 453 8.
95. Layward L, Allen AC, Hattersley JM, Harper SJ, Feehally J. Low antibody affinity restricted to the IgA isotype in IgA nephropathy. Clin. Exp. Immunol. 1994 95 : 35 41.
96. Layward L, Allen AC, Harper SJ, Hattersley JM, Feehally J. Increased and prolonged production of specific polymeric IgA after systemic immunization with tetanus toxoid in IgA nephropathy. Clin. Exp. Immunol. 1992 88 : 394 8.
97. Lamm ME. The IgA mucosal immune system. Am. J. Kidney Dis 1988 12 : 384 7.
98. Harper SJ, Pringle JH, Wicks AC et al. Expression of J chain mRNA in duodenal IgA plasma cells in IgA nephropathy. Kidney Int. 1994 45 : 836 44.
99. Westberg NG, Baklien K, Schmekel B, Gillberg R, Brandtzaeg P. Quantitation of immunoglobulin-producing cells in small intestinal mucosa of patients with IgA nephropathy. Clin. Immunol. Immunopathol. 1983 26 : 442 5.
100. de Fijter JW, Eijgenraam JW, Braam CA et al. Deficient IgA1 immune response to nasal cholera toxin subunit B in primary IgA nephropathy. Kidney Int. 1996 50 : 952 61.
101. Roodnat JI, de Fijter JW, van Kooten C, Daha MR, van Es LA. Decreased IgA1 response after primary oral immunization with live typhoid vaccine in primary IgA nephropathy. Nephrol. Dial. Transplant. 1999 14 : 353 9.
102. Rott LS, Briskin MJ, Andrew DP, Berg EL, Butcher EC. A fundamental subdivision of circulating lymphocytes defined by adhesion to mucosal addressin cell adhesion molecule-1. Comparison with vascular cell adhesion molecule-1 and correlation with beta 7 integrins and memory differentiation. J. Immunol. 1996 156 : 3727 36.
103. Schweighoffer T, Tanaka Y, Tidswell M et al. Selective expression of integrin alpha 4 beta 7 on a subset of human CD4+ memory T cells with Hallmarks of gut-trophism. J. Immunol. 1993 151 : 717 29.
104. Harper SJ, Allen AC, Pringle JH, Feehally J. Increased dimeric IgA producing B cells in the bone marrow in IgA nephropathy determined by in situ hybridisation for J chain mRNA. J. Clin. Pathol. 1996 49 : 38 42.
105. van den Wall Bake AW, Daha MR, Haaijman JJ, Radl J, Van Der Ark A, van Es LA. Elevated production of polymeric and monomeric IgA1 by the bone marrow in IgA nephropathy. Kidney Int. 1989 35 : 1400 404.
106. Barratt J, Batra A, Montgomery U, Feehally J, Smith AC. Increased Systemic Homing CD4 T Cells in IgA Nephropathy. J. Am. Soc. Nephrol. 2003 14 : 886A.
107. Smith AC, Batra A, Barratt J, Montgomery U, Feehally J. Homing Receptor Expression of Peripheral Blood B Cell Subsets in IgA Nephropathy. J. Am. Soc. Nephrol. 2003 14 : 632A.
108. Allen AC, Topham PS, Harper SJ, Feehally J. Leucocyte beta 1,3 galactosyltransferase activity in IgA nephropathy. Nephrol. Dial. Transplant. 1997 12 : 701 6.
109. Buck KS, Barratt J, Feehally J, Smith AC. Beta-1-3-galactosyltransferase activity in IgA nephropathy. J. Am. Soc. Nephrol. 2003 14 : 632A.
110. Gharavi AG, Yan Y, Scolari F et al. IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22-23. Nat. Genet. 2000 26 : 354 7.
111. Li GS, Zhang H, Lv JC, Shen Y, Wang HY. Variants of C1GALT1 gene are associated with the genetic susceptibility to IgA nephropathy. Kidney Int. 2007 71 : 448 531.
112. Alexander WS, Viney EM, Zhang JG et al. Thrombocytopenia and kidney disease in mice with a mutation in the C1galt1 gene. Proc. Natl Acad. Sci. USA 2006 103 : 16442 7.
113. Schietinger A, Philip M, Yoshida BA et al. A mutant chaperone converts a wild-type protein into a tumor-specific antigen. Science 2006 314 : 304 8.
114. Qin W, Zhou Q, Yang LC et al. Peripheral B lymphocyte beta1,3-galactosyltransferase and chaperone expression in immunoglobulin A nephropathy. J. Intern. Med. 2005 258 : 467 77.
115. Breitfeld PP, Simmons CF Jr, Strous GJ, Geuze HJ, Schwartz AL. Cell biology of the asialoglycoprotein receptor system: A model of receptor-mediated endocytosis. Int. Rev. Cytol. 1985 97 : 47 95.
116. Basset C, Devauchelle V, Durand V et al. Basic immunology: Glycosylation of immunoglobulin A influences its receptor binding [In Process Citation]. Scand. J. Immunol. 1999 50 : 572 9.
117. Leung JC, Tang SC, Lam MF, Chan TM, Lai KN. Charge-dependent binding of polymeric IgA1 to human mesangial cells in IgA nephropathy. Kidney Int. 2001 59 : 277 85.
118. Shuib AS, Chua CT, Hashim OH. Sera of IgA nephropathy patients contain a heterogeneous population of relatively cationic alpha-heavy chains. Nephron 1998 78 : 290 95.
119. Mandal C. Sialic acid binding lectins. Experientia 1990 46 : 433 41.